Skip to main content
Clinical Trials/ISRCTN55999335
ISRCTN55999335
Completed
Not Applicable

A randomised placebo-controlled trial of the effect of hormone replacement therapy on dementia and cognitive function in post-menopausal wome

Medical Research Council (MRC) (UK)0 sites14,240 target enrollmentOctober 25, 2000

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstetrics and gynaecology
Sponsor
Medical Research Council (MRC) (UK)
Enrollment
14240
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2000
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Medical Research Council (MRC) (UK)

Eligibility Criteria

Inclusion Criteria

  • Age 50\-69, female, post\-menopausal, no contraindication to HRT.
  • For both components, in addition to the WISDOM trial inclusion criteria, subjects will only be recruited if they can be randomised to receive placebo, ie excluding the 21% of WISDOM recruits with a total hysterectomy who are already taking HRT.
  • For the dementia component sub\-study only those who will reach the age of 65 years before the end of the projected follow\-up period (2009\) will be included.

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials